LFCR
Price
$6.51
Change
+$0.07 (+1.09%)
Updated
Oct 28 closing price
Capitalization
246.42M
8 days until earnings call
Intraday BUY SELL Signals
RDY
Price
$14.15
Change
+$0.40 (+2.91%)
Updated
Oct 28 closing price
Capitalization
11.79B
85 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

LFCR vs RDY

LFCR vs RDY Comparison Chart in %
loading
loading
View a ticker or compare two or three
VS
LFCR vs. RDY commentary
Oct 29, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is LFCR is a Buy and RDY is a StrongBuy.

Interact to see
Advertisement
SUMMARIES
A.I.Advisor
a Summary for LFCR with price predictions
Oct 28, 2026

Momentum Indicator for LFCR turns positive, indicating new upward trend

LFCR saw its Momentum Indicator move above the 0 level on October 26, 2026. This is an indication that the stock could be shifting in to a new upward move. Traders may want to consider buying the stock or buying call options. Tickeron's A.I.dvisor looked at 91 similar instances where the indicator turned positive. In 74 of the 91 cases, the stock moved higher in the following days. The odds of a move higher are at 81%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

LFCR moved above its 50-day moving average on September 28, 2026 date and that indicates a change from a downward trend to an upward trend.

The 10-day moving average for LFCR crossed bullishly above the 50-day moving average on September 28, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 12 of 15 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 80%.

Following a +1.10% 3-day Advance, the price is estimated to grow further. Considering data from situations where LFCR advanced for three days, in 210 of 269 cases, the price rose further within the following month. The odds of a continued upward trend are 78%.

Bearish Trend Analysis

The RSI Indicator demonstrates that the ticker has stayed in the overbought zone for 22 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.

The Stochastic Oscillator entered the overbought zone. Expect a price pull-back in the foreseeable future.

The Moving Average Convergence Divergence Histogram (MACD) for LFCR turned negative on October 15, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 45 similar instances when the indicator turned negative. In 37 of the 45 cases the stock turned lower in the days that followed. This puts the odds of success at 82%.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where LFCR declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 79%.

LFCR broke above its upper Bollinger Band on October 28, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Fundamental Analysis (Ratings)

The Tickeron Seasonality Score of 17 (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron Price Growth Rating for this company is 35 (best 1 - 100 worst), indicating steady price growth. LFCR’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of 55 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (-7.228) is normal, around the industry mean (8.801). P/E Ratio (-5.126) is within average values for comparable stocks, (-2.500). Projected Growth (PEG Ratio) (2.661) is also within normal values, averaging (2.152). Dividend Yield (0.000) settles around the average of (0.044) among similar stocks. P/S Ratio (1.222) is also within normal values, averaging (178.797).

The Tickeron PE Growth Rating for this company is 82 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is 100 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. LFCR’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 84, placing this stock worse than average.

A.I.Advisor
a Summary for RDY with price predictions
Oct 28, 2026

RDY's MACD Histogram crosses above signal line

The Moving Average Convergence Divergence (MACD) for RDY turned positive on October 09, 2026. Looking at past instances where RDY's MACD turned positive, the stock continued to rise in 30 of 47 cases over the following month. The odds of a continued upward trend are 64%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on October 14, 2026. You may want to consider a long position or call options on RDY as a result. In 42 of 84 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 50%.

The 10-day moving average for RDY crossed bullishly above the 50-day moving average on September 24, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 12 of 19 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 63%.

Following a +1.45% 3-day Advance, the price is estimated to grow further. Considering data from situations where RDY advanced for three days, in 154 of 316 cases, the price rose further within the following month. The odds of a continued upward trend are 49%.

The Aroon Indicator entered an Uptrend today. In 89 of 243 cases where RDY Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 37%.

Bearish Trend Analysis

The RSI Indicator has been in the overbought zone for 2 days. Expect a price pull-back in the near future.

The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 11 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where RDY declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 55%.

RDY broke above its upper Bollinger Band on October 28, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Fundamental Analysis (Ratings)

The Tickeron Price Growth Rating for this company is 43 (best 1 - 100 worst), indicating steady price growth. RDY’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of 49 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.031) is normal, around the industry mean (8.801). P/E Ratio (0.356) is within average values for comparable stocks, (-2.500). Projected Growth (PEG Ratio) (1.666) is also within normal values, averaging (2.152). Dividend Yield (0.021) settles around the average of (0.044) among similar stocks. P/S Ratio (2.817) is also within normal values, averaging (178.797).

The Tickeron Profit vs. Risk Rating rating for this company is 69 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. RDY’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 84, placing this stock better than average.

The Tickeron SMR rating for this company is 73 (best 1 - 100 worst), indicating slightly better than average sales and a considerably profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is 97 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

FUNDAMENTALS RATINGS
LFCR vs RDY: Fundamental Ratings
LFCR
RDY
OUTLOOK RATING
1..100
536
VALUATION
overvalued / fair valued / undervalued
1..100
55
Fair valued
49
Fair valued
PROFIT vs RISK RATING
1..100
10069
SMR RATING
1..100
10073
PRICE GROWTH RATING
1..100
3543
P/E GROWTH RATING
1..100
8297
SEASONALITY SCORE
1..100
1750

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

RDY's Valuation (49) in the Pharmaceuticals Generic industry is in the same range as LFCR (55) in the Industrial Specialties industry. This means that RDY’s stock grew similarly to LFCR’s over the last 12 months.

RDY's Profit vs Risk Rating (69) in the Pharmaceuticals Generic industry is in the same range as LFCR (100) in the Industrial Specialties industry. This means that RDY’s stock grew similarly to LFCR’s over the last 12 months.

RDY's SMR Rating (73) in the Pharmaceuticals Generic industry is in the same range as LFCR (100) in the Industrial Specialties industry. This means that RDY’s stock grew similarly to LFCR’s over the last 12 months.

LFCR's Price Growth Rating (35) in the Industrial Specialties industry is in the same range as RDY (43) in the Pharmaceuticals Generic industry. This means that LFCR’s stock grew similarly to RDY’s over the last 12 months.

LFCR's P/E Growth Rating (82) in the Industrial Specialties industry is in the same range as RDY (97) in the Pharmaceuticals Generic industry. This means that LFCR’s stock grew similarly to RDY’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
LFCRRDY
RSI
ODDS (%)
Bearish Trend 1 day ago
87%
Bearish Trend 1 day ago
58%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
84%
Bearish Trend 1 day ago
53%
Momentum
ODDS (%)
Bullish Trend 1 day ago
81%
Bullish Trend 1 day ago
50%
MACD
ODDS (%)
Bearish Trend 1 day ago
82%
Bullish Trend 1 day ago
64%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
80%
Bullish Trend 1 day ago
49%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
74%
Bullish Trend 1 day ago
45%
Advances
ODDS (%)
Bullish Trend 4 days ago
78%
Bullish Trend 10 days ago
49%
Declines
ODDS (%)
Bearish Trend 17 days ago
79%
Bearish Trend 16 days ago
55%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
85%
Bearish Trend 1 day ago
65%
Aroon
ODDS (%)
N/A
Bullish Trend 1 day ago
37%
COMPARISON
Comparison
Oct 29, 2026
Stock price -- (LFCR: $6.51 vs. RDY: $14.15)
Brand notoriety: LFCR and RDY are both not notable
Both companies represent the Pharmaceuticals: Generic industry
Current volume relative to the 65-day Moving Average: LFCR: 74% vs. RDY: 112%
Market capitalization -- LFCR: $246.42M vs. RDY: $11.79B
LFCR [@Pharmaceuticals: Generic] is valued at $246.42M. RDY’s [@Pharmaceuticals: Generic] market capitalization is $11.79B. The market cap for tickers in the [@Pharmaceuticals: Generic] industry ranges from $2.12K to $68.49B. The average market capitalization across the [@Pharmaceuticals: Generic] industry is $4.34B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

LFCR’s FA Score shows that 0 FA rating(s) are green while RDY’s FA Score has 0 green FA rating(s).

  • LFCR’s FA Score: 0 green, 5 red.
  • RDY’s FA Score: 0 green, 5 red.
According to our system of comparison, RDY is a better buy in the long-term than LFCR.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

LFCR’s TA Score shows that 4 TA indicator(s) are bullish while RDY’s TA Score has 5 bullish TA indicator(s).

  • LFCR’s TA Score: 4 bullish, 5 bearish.
  • RDY’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, RDY is a better buy in the short-term than LFCR.

Price Growth

LFCR (@Pharmaceuticals: Generic) experienced а +2.20% price change this week, while RDY (@Pharmaceuticals: Generic) price change was +7.28% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Generic industry was -0.99%. For the same industry, the average monthly price growth was -10.72%, and the average quarterly price growth was +6.10%.

Reported Earning Dates

LFCR is expected to report earnings on Nov 06, 2026.

RDY is expected to report earnings on Jan 22, 2027.

Industries' Descriptions

@Pharmaceuticals: Generic (-0.99% weekly)

A generic drug contains the same chemical substance as a drug that was originally protected by patents. Generic drugs are generally sold at cheaper price points, compared to name-brand pharmaceuticals, after patents for the more expensive drugs lapse. The generic drug industry has created a major market, thanks to the lower pricing. According to the Center for Justice and Democracy at New York Law School, 80 percent of all drugs prescribed are generic, and generic drugs are chosen 94 percent of the time when they are available. But their manufacturers must be able to prove to the FDA that they can be effective substitutes for the original drugs. Some of the major generic drug makers include Zoetis, Inc., Allergan plc and Mylan N.V.

View a ticker or compare two or three
LFCR
Daily Signal:
Gain/Loss:
RDY
Daily Signal:
Gain/Loss:
Interact to see
Advertisement

LFCR and

Correlation & Price change

A.I.dvisor tells us that LFCR and SHPH have been poorly correlated (+31% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that LFCR and SHPH's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To LFCR
1D Price
Change %
LFCR100%
+1.09%
SHPH - LFCR
31%
Poorly correlated
+0.58%
COLL - LFCR
28%
Poorly correlated
+1.00%
PAHC - LFCR
27%
Poorly correlated
-1.30%
TLRY - LFCR
27%
Poorly correlated
-2.89%
VTRS - LFCR
25%
Poorly correlated
+0.27%
More
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
CRYPTO / NAMEPrice $Chg $Chg %
OMNI.X0.000007N/A
+0.66%
OmniCat cryptocurrency
EDU.X0.059405-0.000088
-0.15%
Open Campus cryptocurrency
PENDLE.X1.988925-0.007922
-0.40%
Pendle cryptocurrency
DIA.X0.140007-0.001416
-1.00%
DIA cryptocurrency
KDA.X0.010164-0.000451
-4.25%
Kadena cryptocurrency